Immune Imbalance and Dynamic Characteristics of T Helper 17, Regulatory T, and Regulatory B Cells in Children With Persistent Immune Thrombocytopenia
Pediatric Blood & Cancer · 2026
DOI: 10.1002/1545-5017.70067 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2026. Verfasst von Peiling Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, The First Affiliated Hospital of Xinxiang Medical University, Henan, China. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, B-Lymphocytes, Regulatory, Purpura, Thrombocytopenic, Idiopathic, Th17 Cells. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Henan Province Medical Science and Technology Research Program Joint Construction Project.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objective
This study aimed to explore the dynamic alterations of T helper 17 (Th17) cells, regulatory T (Treg) cells and regulatory B (Breg) cells in children with persistent immune thrombocytopenia (ITP).
Methods
A prospective cohort study was conducted involving 34 children with persistent ITP and 30 age‐ and sex‐matched healthy controls. Peripheral blood samples were collected at baseline and 3 months post‐treatment. T helper 17 and Treg cells were quantified as percentages of CD3⁺CD4⁺ T lymphocytes, and Breg cells as a percentage of CD19⁺ B lymphocytes using BD FACSDx Flex flow cytometry. All patients received standard first‐line treatment with intravenous immunoglobulin and prednisone, and response was evaluated after 3 months.
Results
At baseline, children diagnosed with ITP exhibited a pronounced imbalance in immune cell subsets compared with age‐ and sex‐matched healthy controls. Specifically, Th17 cell levels and the Th17/Treg ratio were significantly elevated (7.81% ± 3.13% vs. 3.30% ± 1.51% and 1.23 ± 0.72 vs. 0.44 ± 0.23, respectively; both p < 0.001), indicating a proinflammatory immune profile. In contrast, the frequencies of immunosuppressive Treg and Breg cells were notably decreased (6.80% ± 1.75% vs. 8.03% ± 1.14%, p = 0.026; 3.10% ± 2.00% vs. 6.61% ± 1.69%, p < 0.001). After 3 months of standardised treatment, no statistically significant changes were observed in the levels of these immune cell subsets or the Th17/Treg ratio compared with pre‐treatment values. Clinically, 73.5% achieved a complete response, 20.6% achieved a partial response, and 5.9% showed no response.
Conclusion
Both Th17/Treg cell imbalance and Breg cell deficiency contribute to the pathogenesis of persistent ITP in children. Concurrent monitoring of these immune subsets may aid in immunophenotyping, and their potential role as biomarkers for treatment outcomes warrants further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, The First Affiliated Hospital of Xinxiang Medical University, Henan, China.
- Department of Laboratory Medicine, The First Affiliated Hospital of Xinxiang Medical University, Henan, China.
ORCID-Profile: Shujun Li
Förderung
- Henan Province Medical Science and Technology Research Program Joint Construction Project
Zitieren
APA
Li, P., Wang, Z., Wang, Z., Fan, R., Guo, J., Dai, X., Zhang, F., Liu, B., Wang, Y., & Li, S. (2026). Immune Imbalance and Dynamic Characteristics of T Helper 17, Regulatory T, and Regulatory B Cells in Children With Persistent Immune Thrombocytopenia. Pediatric Blood & Cancer. https://doi.org/10.1002/1545-5017.70067
Vancouver
Li P, Wang Z, Wang Z, Fan R, Guo J, Dai X, et al. Immune Imbalance and Dynamic Characteristics of T Helper 17, Regulatory T, and Regulatory B Cells in Children With Persistent Immune Thrombocytopenia. Pediatric Blood & Cancer. 2026. doi:10.1002/1545-5017.70067
BibTeX
@article{Li2026,
author = {Li, Peiling and Wang, Zhihang and Wang, Zhiyin and Fan, Rui and Guo, Jia and Dai, Xuyang and Zhang, Fangmin and Liu, Bao and Wang, Yuanfei and Li, Shujun},
title = {Immune Imbalance and Dynamic Characteristics of T Helper 17, Regulatory T, and Regulatory B Cells in Children With Persistent Immune Thrombocytopenia},
journal = {Pediatric Blood & Cancer},
year = {2026},
doi = {10.1002/1545-5017.70067}
}
EUVIMED